CORDIS
EU research results

CORDIS

English EN
Novel Materials and Manifacturing Process Enabling Wristed Micro-Instruments: Business Feasibility Of Surgical Applications

Novel Materials and Manifacturing Process Enabling Wristed Micro-Instruments: Business Feasibility Of Surgical Applications

Objective

MicroInstrmntsBP aims at planning the best business approach to the commercialization of micro-surgical instruments with the same dexterity of state-of-the-art instruments but smaller in size. The reduction in size allows the instruments to be introduced and used in smaller surgical fields and will open up robotic micro-surgery and endoscopic applications, that are currently beyond the capabilities of state-of-the-art products and have an estimated market size 10x the current 2014 market size for wristed surgical instruments (0.5 Billion USD).
Micro-wristed instruments are enabled by a proprietary, integrated design and a proprietary manufacturing process. Medra's design & manufacturing process for 3d micro parts allows parts to mate together with high precision. Current manufacturing technologies are limited in the fabrication of small 3d parts, especially parts for assemblies, by limits on the achievable geometry of the parts and their tolerances. We have overcome such limitations and are able produce very precise small parts in very hard and high yield strength materials. Such an approach allows to counter the weakening of the parts due to the scaling down of the dimensions. 5 month out goals are international IP filings and definition of first viable product based on surgical procedure-specific market size and risk-adjusted business opportunity.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

MEDRA SRL

Address

Via Del Paduletto 10 A
56011 Calci

Italy

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 50 000

Project information

Grant agreement ID: 663776

  • Start date

    1 January 2015

  • End date

    31 May 2015

Funded under:

H2020-EU.2.3.1.

H2020-EU.2.1.2.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

MEDRA SRL

Italy